Cancer Research Horizons
Cancer Research Horizons, headquartered in Great Britain, is a leading entity in the oncology research sector, dedicated to advancing cancer treatments and therapies. Founded in 2021, the organisation has quickly established itself as a pivotal player in the industry, focusing on drug discovery, development, and commercialisation of innovative cancer therapies. With a commitment to transforming scientific breakthroughs into tangible solutions, Cancer Research Horizons offers a unique portfolio of services, including preclinical and clinical trial support. Their collaborative approach with academic institutions and industry partners enhances their ability to deliver cutting-edge solutions. Recognised for their significant contributions to cancer research, the company continues to make strides in improving patient outcomes and solidifying its position as a frontrunner in the fight against cancer.
DitchCarbon Score
How does Cancer Research Horizons's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cancer Research Horizons's score of 8 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cancer Research Horizons's reported carbon emissions
Cancer Research Horizons, headquartered in the United Kingdom, has made significant commitments towards reducing its carbon emissions, although specific emissions data is currently unavailable. The organisation has committed to achieving net-zero emissions across all scopes by 2050, with a start year of 2023. This long-term target aligns with industry standards and reflects a proactive approach to climate action within the pharmaceuticals, biotechnology, and life sciences sector. As part of its climate strategy, Cancer Research Horizons has engaged with the Science Based Targets initiative (SBTi) and is classified as "Committed" to its net-zero goals. The company has also demonstrated its dedication to sustainability by adhering to the Business Ambition for 1.5°C framework since July 2022. While no absolute emissions figures are provided, Cancer Research Horizons's commitment to net-zero emissions underscores its role in addressing climate change and promoting environmental responsibility within its industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cancer Research Horizons is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
